Interest of Auriculotherapy in the Treatment of Xerostomia

Launched by HOPITAL FOCH · Jan 7, 2020

Keywords

ClinConnect Summary

This clinical trial is investigating whether auriculotherapy, a treatment that involves stimulating specific points on the ear, can help relieve xerostomia, which is a condition causing dry mouth. This condition often occurs after patients have undergone radiation therapy for head and neck cancers. The study is currently looking for participants aged 18 and older who have experienced dry mouth for at least three months after their radiation treatment.

To be eligible for the trial, participants should not be pregnant or breastfeeding, and they should not have certain medical conditions or treatments that could interfere with the study. Those who join the trial will receive auriculotherapy sessions and may complete questionnaires to help researchers understand the treatment's effectiveness. This study is important as it aims to find new ways to help patients manage dry mouth, improving their quality of life after cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years old;
• • Complain about xerostomia after cervical irradiation in the context of ENT cancer;
• • End of radiotherapy\> 3 months
• • Covered by a national healthcare insurance
• • Consent form signed.
• Non inclusion Criteria:
• • Pregnant or breastfeeding women;
• • Local counterindication to auriculotherapy;
• • With anticoagulant treatment;
• • History or existing of hemophilia;
• • Valvular prosthesis;
• • Ear's pavilion infection;
• • Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
• • Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management);
• • Difficulty to comply with the treatment, questionnaires or study protocol;
• • Being deprived of liberty or under guardianship.